• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (6)
    • Clinical characteristics, visceral involvement, and mortality in at-risk or early diffuse systemic sclerosis: a longitudinal analysis of an observational prospective multicenter US cohort.
    • Editorial: Acid perfusion revisited.
    • Exhalation delivery system with fluticasone improves quality of life and health status: pooled analysis of phase 3 trials NAVIGATE I and II.
    • Reports of clinical trials: ethical aspects.
    • Controversies in COX-2 selective inhibition.
    • See All 6 Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

Controversies in COX-2 selective inhibition.

Controversies in COX-2 selective inhibition. J Rheumatol. 2002 Jul; 29(7):1501-10.

View in: PubMed

subject areas
  • Anti-Inflammatory Agents, Non-Steroidal
  • Arthritis, Rheumatoid
  • Aspirin
  • Cyclooxygenase Inhibitors
  • Dose-Response Relationship, Drug
  • Drug Interactions
  • Female
  • Gastrointestinal Diseases
  • Humans
  • Male
  • Maximum Tolerated Dose
  • Randomized Controlled Trials as Topic
  • Risk Assessment
  • Sensitivity and Specificity

authors with profiles
  • Raymond N. DuBois